Sep 2026· The Turkish Journal of Gastroenterology· 1 citation· 34 references
Medicine
TL;DR
The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization.
Abstract
Disorders of gut-brain interaction (DGBIs), traditionally termed functional gastrointestinal disorders, affect approximately 15% of adults worldwide and are characterized by chronic digestive symptoms without identifiable structural abnormalities. According to the recently updated Rome V framework, DGBIs are characterized by pathogenic dysregulation of bidirectional communication among the central nervous system, enteric nervous system, and intestinal microbiota. This review examines the anatomical and molecular foundations of gut-brain axis (GBA) communication, emphasizing the roles of microbial metabolites (e.g., short-chain fatty acids and tryptophan derivatives) in neuroimmune modulation and visceral sensitivity. The authors analyze GBA dysfunction across major DGBIs subtypes (irritable bowel syndrome, functional dyspepsia, and functional abdominal pain syndrome), highlighting microbiota dysbiosis, barrier dysfunction, and central sensitization. Current therapies include psychological interventions, neuromodulation, microbiota-targeted approaches, dietary management, and pharmacotherapy; however, treatment responses remain highly heterogeneous across patient populations, highlighting the potential value of biomarker-guided and mechanism based therapeutic approaches. Future paradigms will require multiomics profiling, artificial intelligence, and precision medicine to develop mechanism-based diagnostics and individualized treatments, advancing care from symptom-focused to mechanism-targeted approaches.
The gut–brain axis is a bidirectional communication network linking the gastrointestinal tract and the central nervous system (CNS), in which the gut microbiota and its metabolites have emerged as important modulators. Alterations in the gut microbiota have been reported in a range of neurological, psychiatric, and met...
Le-Le Fan, Yu Guo, Jin Liu et al.· Frontiers in Microbiology· 0 citations
Current knowledge on the mechanisms by which gut microbiota may influence mental health and microbiota-targeted therapeutic approaches are summarized to clarify causal mechanisms, identify effective microbial interventions, and determine their place in mental health prevention and treatment are summarized.
Agnieszka Kafara, Zuzanna Kafara, Julia Koronczok-Matusiak et al.· International Journal of Inn...· 0 citations
The interaction between gut microbiota and neuroinflammation in ASD is reviewed to provide insights for treatment and research, aiming to provide insights for treatment and research.
Cong Hu, He-Li Li, Yun-Jie Li et al.· Current Neuropharmacology· 0 citations
Current evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pathways, and available evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pa...
Monika Sas-Wyżykowska, Anna Wyżykowska, M. Maruszak et al.· International Journal of Inn...· 0 citations
The link between gut dysbiosis and clinically significant neurological disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and neuropsychiatric disorders is extensively analyzed, and the research considers novel microbiome-based approaches, probiotics, prebiotics, synbiot...
Bhoomi Aggarwal, Nyasa Pandey, S. Anand et al.· Genetics and Molecular Resea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.